ROIV
Roivant Sciences Ltd. · Healthcare
Director Daniel Allen Gold sold $26.9M of Roivant Sciences Ltd.
Sold$26,866,385
$4.75Price
5,656,081Shares
−4%Stake
What ROIV did after the filing
- The stock from Tue, Nov 15 open, $5.50
- +43.3%
- S&P 500, same days
- −4.0%
Measured over 30 trading days, to the Dec 29 close.
Traded Thu, Nov 10. Filed Mon, Nov 14, 9:44 PM ET, after the close. Returns use the Nov 15 open and the Dec 29 close. Not investment advice.